Current Illinois CancerCare Clinical Trials

The National Myelodysplastic Syndromes (MDS) Study (Suspended)

Study Number: NHLBI MDS (Suspended)

Study Summary:
Multi-center study enrolling patients suspected or newly diagnosed with myelodysplastic syndromes (MDS), myelodysplastic syndromes/myeloproliferative neoplasms (MDS/MPN) overlap disorder, or idiopathic cytopenia of undetermined significance (ICUS). Participants will be followed long term. Clinical data, blood, and tissue samples will be collected to establish a biorepository to facilitate the study of the natural history of MDS.

Status: Suspended

Peoria, Bloomington, and Galesburg only

Study Coordinator(s)
  • Navigator Heather, 309-243-3661
  • Hannah, 309-243-3628

Study Link

« Search Again